What are LG Chem's three core future businesses announced on June 22, and how does the company plan to prioritize R&D investment among them?

LG Chem announced semiconductor/Mobility/robotics materials and anticancer new drugs as its future core businesses. The company plans to invest a total of 15 trillion KRW in R&D by 2035, with 70% of R&D resources concentrated on semiconductor/Mobility/robotics materials—specifically targeting advanced packaging materials such as bonding agents, low-dielectric materials, thermal management materials, and glass substrates—and ensuring AI-based innovation and leading technologies in these areas.

How is LG Chem transforming its business model beyond traditional material supply, and what strategic organizational change supports this shift?

LG Chem is transforming from a single-material supplier into a 'comprehensive solutions enterprise' that co-designs both customer product performance and manufacturing processes. To accelerate this strategic shift, the company established a new CEO-directly supervised business development organization in June 2024 to drive implementation of its portfolio optimization and upgrade initiatives.

LG Chem Accelerates Business Portfolio Optimization and Upgrade

Jun 26, 2026

LG Chem announces strategic pivot to semiconductor, mobility, robotics materials, and anti-cancer drugs amid shrinking chemical profits. Plans 15 trillion KRW R&D by 2035, targeting 2 trillion KRW in electronic materials by 2030.

ccin

2026-01-23

LG Chem Partners with Yinglian to Establish Joint Lab for Lithium Battery Material Innovation

2026-01-29

LG Chem's petchem losses widen on narrowing margins, one-off overseas costs

2026-02-11

Activist UK Investor Calls on LG Chem to Restore Share Performance, Monetize LGES Stake

2026-03-05

LG Chem to Cut Cracker Run Rates to 60%

2026-03-06

LG Chem declares force majeure on certain DOTP export contracts